315 related articles for article (PubMed ID: 26178787)
1. Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.
Chiou SH; Winters IP; Wang J; Naranjo S; Dudgeon C; Tamburini FB; Brady JJ; Yang D; Grüner BM; Chuang CH; Caswell DR; Zeng H; Chu P; Kim GE; Carpizo DR; Kim SK; Winslow MM
Genes Dev; 2015 Jul; 29(14):1576-85. PubMed ID: 26178787
[TBL] [Abstract][Full Text] [Related]
2. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9 knockin mice for genome editing and cancer modeling.
Platt RJ; Chen S; Zhou Y; Yim MJ; Swiech L; Kempton HR; Dahlman JE; Parnas O; Eisenhaure TM; Jovanovic M; Graham DB; Jhunjhunwala S; Heidenreich M; Xavier RJ; Langer R; Anderson DG; Hacohen N; Regev A; Feng G; Sharp PA; Zhang F
Cell; 2014 Oct; 159(2):440-55. PubMed ID: 25263330
[TBL] [Abstract][Full Text] [Related]
4. Rapid modelling of cooperating genetic events in cancer through somatic genome editing.
Sánchez-Rivera FJ; Papagiannakopoulos T; Romero R; Tammela T; Bauer MR; Bhutkar A; Joshi NS; Subbaraj L; Bronson RT; Xue W; Jacks T
Nature; 2014 Dec; 516(7531):428-31. PubMed ID: 25337879
[TBL] [Abstract][Full Text] [Related]
5. A versatile modular vector system for rapid combinatorial mammalian genetics.
Albers J; Danzer C; Rechsteiner M; Lehmann H; Brandt LP; Hejhal T; Catalano A; Busenhart P; Gonçalves AF; Brandt S; Bode PK; Bode-Lesniewska B; Wild PJ; Frew IJ
J Clin Invest; 2015 Apr; 125(4):1603-19. PubMed ID: 25751063
[TBL] [Abstract][Full Text] [Related]
6.
Chang YJ; Bae J; Zhao Y; Lee G; Han J; Lee YH; Koo OJ; Seo S; Choi YK; Yeom SC
J Vet Sci; 2020 Mar; 21(2):e26. PubMed ID: 32233134
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
Mazur PK; Herner A; Mello SS; Wirth M; Hausmann S; Sánchez-Rivera FJ; Lofgren SM; Kuschma T; Hahn SA; Vangala D; Trajkovic-Arsic M; Gupta A; Heid I; Noël PB; Braren R; Erkan M; Kleeff J; Sipos B; Sayles LC; Heikenwalder M; Heßmann E; Ellenrieder V; Esposito I; Jacks T; Bradner JE; Khatri P; Sweet-Cordero EA; Attardi LD; Schmid RM; Schneider G; Sage J; Siveke JT
Nat Med; 2015 Oct; 21(10):1163-71. PubMed ID: 26390243
[TBL] [Abstract][Full Text] [Related]
8. Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing.
Mishra A; Emamgholi F; Erlangga Z; Hartleben B; Unger K; Wolff K; Teichmann U; Kessel M; Woller N; Kühnel F; Dow LE; Manns MP; Vogel A; Lowe SW; Saborowski A; Saborowski M
Carcinogenesis; 2020 May; 41(3):334-344. PubMed ID: 31170286
[TBL] [Abstract][Full Text] [Related]
9. Implementation of CRISPR/Cas9 Genome Editing to Generate Murine Lung Cancer Models That Depict the Mutational Landscape of Human Disease.
Hartmann O; Reissland M; Maier CR; Fischer T; Prieto-Garcia C; Baluapuri A; Schwarz J; Schmitz W; Garrido-Rodriguez M; Pahor N; Davies CC; Bassermann F; Orian A; Wolf E; Schulze A; Calzado MA; Rosenfeldt MT; Diefenbacher ME
Front Cell Dev Biol; 2021; 9():641618. PubMed ID: 33738287
[TBL] [Abstract][Full Text] [Related]
10. SEMMs: Somatically Engineered Mouse Models. A New Tool for
Lima A; Maddalo D
Front Oncol; 2021; 11():667189. PubMed ID: 33968774
[TBL] [Abstract][Full Text] [Related]
11. Efficient and multiplexed somatic genome editing with Cas12a mice.
Hebert JD; Xu H; Tang YJ; Ruiz PA; Detrick CR; Wang J; Hughes NW; Donosa O; Andrejka L; Karmakar S; Aboiralor I; Tang R; Sage J; Cong L; Petrov DA; Winslow MM
bioRxiv; 2024 May; ():. PubMed ID: 38496463
[TBL] [Abstract][Full Text] [Related]
12. Pre-Clinical Models to Study Human Prostate Cancer.
Thomsen MK; Busk M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686488
[TBL] [Abstract][Full Text] [Related]
13. Advances in Immunocompetent Mouse and Rat Models.
Bu W; Li Y
Cold Spring Harb Perspect Med; 2024 Mar; 14(3):. PubMed ID: 37217281
[TBL] [Abstract][Full Text] [Related]
14. A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.
Rogers ZN; McFarland CD; Winters IP; Naranjo S; Chuang CH; Petrov D; Winslow MM
Nat Methods; 2017 Jul; 14(7):737-742. PubMed ID: 28530655
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed pancreatic genome engineering and cancer induction by transfection-based CRISPR/Cas9 delivery in mice.
Maresch R; Mueller S; Veltkamp C; Öllinger R; Friedrich M; Heid I; Steiger K; Weber J; Engleitner T; Barenboim M; Klein S; Louzada S; Banerjee R; Strong A; Stauber T; Gross N; Geumann U; Lange S; Ringelhan M; Varela I; Unger K; Yang F; Schmid RM; Vassiliou GS; Braren R; Schneider G; Heikenwalder M; Bradley A; Saur D; Rad R
Nat Commun; 2016 Feb; 7():10770. PubMed ID: 26916719
[TBL] [Abstract][Full Text] [Related]
16. A Genome-wide CRISPR Screen in Primary Immune Cells to Dissect Regulatory Networks.
Parnas O; Jovanovic M; Eisenhaure TM; Herbst RH; Dixit A; Ye CJ; Przybylski D; Platt RJ; Tirosh I; Sanjana NE; Shalem O; Satija R; Raychowdhury R; Mertins P; Carr SA; Zhang F; Hacohen N; Regev A
Cell; 2015 Jul; 162(3):675-86. PubMed ID: 26189680
[TBL] [Abstract][Full Text] [Related]
17. Single-Step Generation of Conditional Knockout Mouse Embryonic Stem Cells.
Flemr M; Bühler M
Cell Rep; 2015 Jul; 12(4):709-16. PubMed ID: 26190102
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice.
Weber J; Öllinger R; Friedrich M; Ehmer U; Barenboim M; Steiger K; Heid I; Mueller S; Maresch R; Engleitner T; Gross N; Geumann U; Fu B; Segler A; Yuan D; Lange S; Strong A; de la Rosa J; Esposito I; Liu P; Cadiñanos J; Vassiliou GS; Schmid RM; Schneider G; Unger K; Yang F; Braren R; Heikenwälder M; Varela I; Saur D; Bradley A; Rad R
Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13982-7. PubMed ID: 26508638
[TBL] [Abstract][Full Text] [Related]
19. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.
Schumann K; Lin S; Boyer E; Simeonov DR; Subramaniam M; Gate RE; Haliburton GE; Ye CJ; Bluestone JA; Doudna JA; Marson A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10437-42. PubMed ID: 26216948
[TBL] [Abstract][Full Text] [Related]
20. Expression of CRISPR/Cas single guide RNAs using small tRNA promoters.
Mefferd AL; Kornepati AV; Bogerd HP; Kennedy EM; Cullen BR
RNA; 2015 Sep; 21(9):1683-9. PubMed ID: 26187160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
